At A Glance
- This Alert Affects
- If you have used Bextra as directed by a doctor and suffered a heart attack, stroke, or serious skin reactions, you may be entitled to compensation.
- Use of Bextra has been shown to produce higher than normal cardiovascular events for patients. This includes heart attacks and strokes. It has also been linked to potentially life threatening skin conditions including Stevens Johnson Syndrome, toxic epidermal necrolysis, and erythema multiforme.
- Additional Details
- Bextra is prescription drug used to treat arthritis, menstrual cramps, and associated problems. It is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and helps reduce pain, swelling, and fever without causing stomach irritation.
- On April 7, 2005, Pfizer removed Bextra from the market in response to pressure from the FDA.